Aligos Therapeutics, Inc.ALGSNASDAQ
Loading
Total Costs & Expenses Over TimeStable
Percentile Rank29
3Y CAGR-6.8%
5Y CAGR-1.6%
Year-over-Year Change
Total of all costs and expenses
3Y CAGR
-6.8%/yr
vs +69.0%/yr prior
5Y CAGR
-1.6%/yr
Recent deceleration
Acceleration
-75.8pp
Decelerating
Percentile
P29
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
4 yr
Consecutive declineStable
| Period | Value | YoY Change |
|---|---|---|
| TTM | $90.17M | -3.1% |
| 2024 | $93.10M | -10.2% |
| 2023 | $103.66M | -7.0% |
| 2022 | $111.49M | -16.0% |
| 2021 | $132.68M | +35.6% |
| 2020 | $97.83M | +81.0% |
| 2019 | $54.04M | +295.6% |
| 2018 | $13.66M | - |